BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8180132)

  • 1. AP-1 and Krox-24 transcription factors activate the neurofilament light gene promoter in P19 embryonal carcinoma cells.
    Pospelov VA; Pospelova TV; Julien JP
    Cell Growth Differ; 1994 Feb; 5(2):187-96. PubMed ID: 8180132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
    Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
    Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
    Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
    Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
    Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
    Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of the 120 kDa component of the human nuclear factor of activated T cells (NF-AT): reconstitution of binding activity to the cis-acting element of the GM-CSF and IL-2 promoter with AP-1.
    Tokumitsu H; Masuda ES; Tsuboi A; Arai K; Arai N
    Biochem Biophys Res Commun; 1993 Oct; 196(2):737-44. PubMed ID: 8240350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the rat light neurofilament (NF-L) gene promoter and identification of NGF and cAMP responsive regions.
    Reeben M; Neuman T; Palgi J; Palm K; Paalme V; Saarma M
    J Neurosci Res; 1995 Feb; 40(2):177-88. PubMed ID: 7745611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
    Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
    FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PEA3 site flanked by SP1, SP4, and GATA sites positively regulates the differentiation-dependent expression of Brachyury in embryonal carcinoma P19 cells.
    Yamaguchi H; Tanaka K; Kitagawa Y; Miki K
    Biochem Biophys Res Commun; 1999 Jan; 254(3):542-7. PubMed ID: 9920775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity.
    Hilberg F; Wagner EF
    Oncogene; 1992 Dec; 7(12):2371-80. PubMed ID: 1281302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A protein.
    Brockmann D; Schäfer D; Kirch HC; Esche H
    Oncogene; 1996 Apr; 12(8):1715-25. PubMed ID: 8622892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
    Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
    Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel SP3 binding site in the promoter of human IGFBP4 gene: role of SP3 and AP-1 in regulating promoter activity in CaCo2 cells.
    Shen Q; Singh P
    Oncogene; 2004 Apr; 23(14):2454-64. PubMed ID: 14767471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated expression of Krox-24 and other serum-responsive genes during differentiation of P19 embryonal carcinoma cells.
    Lanoix J; Belhumeur P; Lussier M; Royal A; Bravo R; Skup D
    Cell Growth Differ; 1991 Aug; 2(8):391-9. PubMed ID: 1793734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors.
    Wang CY; Bassuk AG; Boise LH; Thompson CB; Bravo R; Leiden JM
    Mol Cell Biol; 1994 Feb; 14(2):1153-9. PubMed ID: 8289796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of human choline acetyltransferase by AP2- and NGF-induced factors.
    Quirin-Stricker C; Mauvais C; Schmitt M
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):165-74. PubMed ID: 9387876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF-induced jun B-expression in transfected P19 embryonal carcinoma cells expressing EGF-receptors is dependent on Jun D.
    den Hertog J; de Groot RP; de Laat SW; Kruijer W
    Nucleic Acids Res; 1992 Jan; 20(1):125-30. PubMed ID: 1738590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene product p53 is involved in the regulation of activity of the c-fos proto-oncogene promotor].
    Vikhanskaia FL; Pospelova TV; Volkov IV; Kukushkin AN; Svetlikova SB; Poslepov VA
    Dokl Akad Nauk SSSR; 1991; 321(4):846-9. PubMed ID: 1806357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.